ACIP Presentation Slides: June 2017 Meeting

June 21, 2017

Welcome & Introductions

• Opening[3 MB, 7 pages]
• Welcome[15 pages]
  Dr. N Bennett
  Dr. A Cohn

Hepatitis Vaccines

• Hepatitis vaccines[9 pages]
  Dr. A Reingold
• Hepatitis A Vaccine Background[2 MB, 42 pages]
  Dr. N Nelson
• Cost-effectiveness analysis of catch-up hepatitis A vaccination among unvaccinated/partially-vaccinated children[23 pages]
  Dr. D Rein
• Updated ACIP routine recommendations for use of hepatitis A vaccine[16 pages]
  Dr. N Nelson
• Updated ACIP recommendations for use of hepatitis A vaccine and immune globulin for post-exposure prophylaxis and for international travelers[27 pages]
  Dr. R Link-Gelles

Influenza

• Introduction[5 pages]
  Dr. E Walter
• Influenza surveillance update[11 pages]
  Ms. A Budd
• Vaccine effectiveness update[19 pages]
  Dr. J Ferdinands
• Vaccine safety update[31 pages]
  Dr. T Shimabukuro
• Flublok in pregnancy[10 pages]
  Dr. W Hachey
• Proposed recommendations[20 pages]
  Dr. L Grohskopf

Herpes Zoster Vaccine

• Herpes Zoster Work Group Activity Update[7 pages]
  Dr. E Belongia
• Grading of Recommendations Assessment, Development and Evaluation (GRADE): live attenuated herpes zoster vaccine (ZVL)[31 pages]
  Ms. A Guo
• Immunogenicity and Safety of Shingrix in Adults Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine (Zoster-048 Study)[24 pages]
  Dr. R Colindres
• Overview of two economic models that assess the cost-effectiveness of herpes zoster vaccinations[33 pages]
  Dr. A Leidner
• Considerations for the use of herpes zoster vaccines[2 MB, 26 pages]
  Dr. K Dooling

Varicella

• The Impact of the U.S. Varicella Vaccination Program on the Incidence of Herpes Zoster[2 MB, 26 pages]
  Dr. R Harpaz

June 22, 2017

 Dengue Virus Vaccines

• Dengue Epidemiology in the United States and U.S. Territories: Perspective as a Vaccine Preventable Disease[2 MB, 36 pages]
  Dr. S Waterman

 Yellow Fever Vaccine

• Yellow Fever Vaccine[4 pages]
  Dr. E Walter
• Yellow Fever Vaccine: Update on Implementation of IND Protocol and Vaccine Distribution[9 pages]
  Dr. D Greenberg
• Review current ACIP recommendations for yellow fever vaccine and expanded access program protocol criteria for Stamaril[9 pages]
  Dr. JE Staples

Mumps Disease and Vaccine

• Mumps Work Group[6 pages]
  Dr. K Moore
• Update on Mumps Epidemiology in the United States, 2017 and Review of Studies of 3rd Dose of MMR Vaccine[2 MB, 28 pages]
  Dr. M Marin 

Meningococcal

• Meningococcal Vaccines Session[8 pages]
  Dr. D Stephens
• Meningococcal Disease in Patients Receiving Eculizumab in the United States[1 MB, 45 pages]
  Dr. L McNamara

Vaccine Adverse Event Reporting System (VAERS)

• Vaccine safety: announcement of the new Vaccine Adverse Event Reporting System (VAERS) 2.0 form[10 pages]
  Dr. T Shimabukuro